ScopusElsevier Scopus
Status
Active
Coverage
1959–present
Source type
Journal
Open access
No
CiteScore
7.8
SJR · SCImago
1.147
Q1 SJR quartile
H-index
224
Best quartile
Q1 · 79th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 67 / 328 | 79th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Psychopharmacology
Psychopharmacology is Scopus-indexed (Q1, CiteScore 7.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 0033-3158Verify ISSN ↗1432-2072Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Scopus · Q1WoS · SCIEONOS
7.8
CiteScore 2025
Q1
Best quartile
2
Indexed in
Cost to publish: About US$4,390 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Psychopharmacology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1959–present, best quartile Q1, CiteScore 7.8.
What quartile is Psychopharmacology in Scopus?
Psychopharmacology is Q1 in Pharmacology (rank 67 of 328), by CiteScore 2025.
What is the impact factor of Psychopharmacology?
Psychopharmacology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.8, which places it in quartile Q1 at the 79th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.147, quartile Q1, with an H-index of 224.
How much does it cost to publish in Psychopharmacology?
The publisher lists an article processing charge of about US$4,390 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Psychopharmacology and what is its ISSN?
Psychopharmacology is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 0033-3158 and its online ISSN is 1432-2072.
Is Psychopharmacology covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Psychopharmacology in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Psychopharmacology open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Psychopharmacology? — open metrics via OpenAlex
Psychopharmacology has an h-index of 289 and a 2-year mean of 3.18 citations per paper (OpenAlex). Its Scopus CiteScore is 7.8, quartile Q1. On 2-year citations it ranks #108 of 319 Scopus journals in Pharmacology.
289
h-index
3.18
2-yr mean citations
14,880
i10-index
18,566
works indexed
939,393
total citations
Publication fee · open access list price, US$
US$4,390
2-yr mean citations, among Scopus journals in the same subject
#108 of 319 Top 34% Pharmacology
Psychopharmacology published 260 papers in 2025; its busiest recent year was 2018 with 321. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Psychopharmacology? — latest 100 articles, 2026
In its latest 100 research articles (2026), authors are most often from United States (37.8%), Australia (7.8%) and Canada (7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Psychopharmacology? — indicators, not proof of misconduct
Scopus status: Active. 18 retracted papers are recorded (1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 18 · 1 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Quantum Machine Intelligence Scopus Q1 WoS ESCI Radiation and Environmental Biophysics Scopus Q2 WoS SCIE Recent Results in Cancer Research Scopus Q3 Regenerative Engineering and Translational Medicine Scopus Q2 WoS ESCI Regional Environmental Change Scopus Q2 WoS SCIE/SSCI Rendiconti Lincei Scopus Q1 WoS SCIE Research for Development Scopus Q3 Results and Problems in Cell Differentiation Scopus Q4
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.